Press coverage about Kewaunee Scientific (NASDAQ:KEQU) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Kewaunee Scientific earned a news impact score of 0.22 on Accern’s scale. Accern also assigned news articles about the technology company an impact score of 48.68846284726 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Kewaunee Scientific (NASDAQ KEQU) traded up $0.43 during mid-day trading on Friday, reaching $29.95. 17,701 shares of the company’s stock were exchanged, compared to its average volume of 4,487. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.58 and a current ratio of 2.12. Kewaunee Scientific has a 1 year low of $22.00 and a 1 year high of $31.20. The company has a market capitalization of $80.32, a PE ratio of 16.10 and a beta of 0.03.
Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Tuesday, February 27th. The technology company reported $0.71 EPS for the quarter. Kewaunee Scientific had a net margin of 3.47% and a return on equity of 14.14%. The firm had revenue of $38.19 million during the quarter.
In other news, Director Donald F. Shaw bought 888 shares of the company’s stock in a transaction dated Tuesday, December 26th. The stock was bought at an average price of $28.78 per share, with a total value of $25,556.64. Following the completion of the acquisition, the director now owns 21,250 shares of the company’s stock, valued at $611,575. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Donald F. Shaw purchased 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 27th. The stock was bought at an average cost of $28.79 per share, with a total value of $57,580.00. The disclosure for this purchase can be found here. 20.20% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Kewaunee Scientific (KEQU) Receives News Sentiment Score of 0.22” was first published by BBNS and is owned by of BBNS. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://baseballnewssource.com/2018/03/10/kewaunee-scientific-kequ-receives-news-sentiment-score-of-0-22/2001380.html.
About Kewaunee Scientific
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.